Market Tracker

07/31 6:01pm ET

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

10.91
Delayed Data
As of Jul 31
 +0.40 / +3.81%
Today’s Change
1.46
Today|||52-Week Range
11.65
+590.51%
Year-to-Date

Today’s Trading

Previous close10.51
Today’s open10.37
Day’s range10.30 - 11.25
Volume1,193,512
Average volume (3 months)1,223,598
Market cap$427.1M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+19.53%
Earnings growth (this year)+17.65%
Earnings growth (next 5 years)+78.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
INFIInfinity Pharmaceuti...+0.01+0.11%
TBPHTheravance Biopharma...+0.49+4.07%
IDRAIdera Pharmaceutical...+0.13+3.77%
RGLSRegulus Therapeutics...-0.06-0.73%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$0.00
Annual profit (last year)-$29.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Paul F. Truex
CAO, Senior VP-Finance &
Administration
May Liu
Corporate headquarters
Hayward, California

Forecasts